PropertyValue
?:definition
  • A monoclonal antibody against beta-amyloid (Abeta40/42) used in the treatment of Alzheimer\'s disease. Gantenerumab targets and binds to beta amyloid then is removed through effector cell-mediated clearance. This reduces the level of beta amyloid in the brain. In Alzheimer\'s disease, beta amyloid accumulates in the brain and is a key component in plaque formation.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C2982066_NCI>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C2982066_NCI>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all